cas 51119-07-4|| where to buy N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide

Nombre del producto:N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide

IUPAC Name:N-{pyrazolo[1,5-a]pyridin-2-yl}acetamide

: CAS：51119-07-4; Fórmula molecular：C9H9N3O; Pureza：97%

: Número de catálogo：CM288851; Peso molecular：175.19

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM288851-1g	1-2 Weeks	ƀǊȬ

Consulta: sales@chemenu.com

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 51119-07-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

Detalles del producto

: Núm. De CAS :51119-07-4; Fórmula molecular:C9H9N3O; Punto de fusión:-; Código de sonrisas:CC(NC1=NN2C=CC=CC2=C1)=O; Densidad:

: Número de catálogo:CM288851; Peso molecular:175.19; Punto de ebullición:; Nº Mdl:; Almacenamiento:

Category Infos

: Pyrazolopyridines; Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

Product Other Information

Product Overview	N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide, also known as PAP-1, is a small molecule compound that has gained significant attention in scientific research due to its potential therapeutic applications. PAP-1 is a potent and selective activator of the enzyme protein kinase R (PKR), which plays a crucial role in the regulation of various cellular processes.
Synthesis and Application	The synthesis of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide involves the reaction of 2-aminopyridine with ethyl chloroacetate, followed by cyclization with hydrazine hydrate. The resulting product is then subjected to further reactions to yield the final compound, N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide. N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide has been extensively studied in scientific research for its potential therapeutic applications. It has been shown to have anti-inflammatory, anti-viral, and anti-tumor properties. N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide has been found to be effective in the treatment of various diseases, including cancer, viral infections, and autoimmune disorders.
Future Directions	There are several future directions for the research on N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide. One potential direction is to investigate the use of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide in the treatment of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis. Another direction is to explore the use of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide in combination with other drugs to enhance their efficacy in the treatment of cancer and viral infections. Additionally, further studies are needed to elucidate the precise mechanism of action of N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide and its potential side effects.